Yutian Zou

4.5k total citations · 6 hit papers
67 papers, 3.1k citations indexed

About

Yutian Zou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yutian Zou has authored 67 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 30 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Yutian Zou's work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yutian Zou is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yutian Zou collaborates with scholars based in China, United States and Hong Kong. Yutian Zou's co-authors include Hailin Tang, Shaoquan Zheng, Xiaoming Xie, Jindong Xie, Xinpei Deng, Yuhui Tang, Anli Yang, Xinhua Xie, W. H. Tian and Danhui Ma and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Yutian Zou

63 papers receiving 3.1k citations

Hit Papers

Leveraging diverse cell-death patterns to predict the pro... 2022 2026 2023 2024 2022 2022 2022 2024 2025 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
    2022 248 citations Yutian Zou, Jindong Xie et al. profile →
  2. The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
    2022 191 citations Yutian Zou, Feng Ye et al. Advanced Science profile →
  3. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
    2022 167 citations Yutian Zou, Shaoquan Zheng et al. Nature Communications profile →
  4. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
    2024 50 citations Jindong Xie, Xinpei Deng et al. SHILAP Revista de lepidopterología profile →
  5. Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
    2025 20 citations Jindong Xie, Xinmei Lin et al. Cancer Drug Resistance profile →
  6. Clinical approaches to overcome PARP inhibitor resistance
    2025 20 citations Yutian Zou, Hailin Tang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutian Zou China 33 2.0k 1.4k 1.0k 782 397 67 3.1k
Mónica V. Estrada United States 16 1.3k 0.6× 925 0.7× 1.4k 1.3× 677 0.9× 245 0.6× 25 2.5k
Andreas Pircher Austria 27 1.7k 0.8× 931 0.7× 1.5k 1.4× 855 1.1× 871 2.2× 103 3.4k
Haili Qian China 31 1.6k 0.8× 790 0.6× 1.0k 1.0× 424 0.5× 264 0.7× 114 2.7k
Giulio Francia United States 31 1.5k 0.7× 849 0.6× 1.5k 1.4× 540 0.7× 346 0.9× 69 3.2k
Mohammed A. Aleskandarany United Kingdom 36 1.7k 0.8× 1.5k 1.1× 1.6k 1.6× 510 0.7× 286 0.7× 81 3.4k
Adrian M. Jubb United Kingdom 32 2.5k 1.2× 1.0k 0.7× 1.6k 1.6× 630 0.8× 351 0.9× 50 4.0k
Hege G. Russnes Norway 23 1.6k 0.8× 1.5k 1.1× 1.1k 1.1× 397 0.5× 205 0.5× 55 3.0k
Marco Gerlinger United Kingdom 22 1.1k 0.5× 1.2k 0.8× 955 0.9× 647 0.8× 233 0.6× 62 2.4k
Oddbjørn Straume Norway 31 2.8k 1.4× 1.3k 0.9× 2.4k 2.3× 694 0.9× 495 1.2× 69 4.6k
Matthias Bache Germany 32 1.7k 0.8× 818 0.6× 794 0.8× 616 0.8× 177 0.4× 105 2.7k

Countries citing papers authored by Yutian Zou

Since Specialization
Citations

This map shows the geographic impact of Yutian Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutian Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutian Zou more than expected).

Fields of papers citing papers by Yutian Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutian Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutian Zou. The network helps show where Yutian Zou may publish in the future.

Co-authorship network of co-authors of Yutian Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Yutian Zou. A scholar is included among the top collaborators of Yutian Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutian Zou. Yutian Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xinpei, et al.. (2025). Disulfidptosis in cancer: from redox stress to therapeutic strategy. Cancer Gene Therapy. 33(1). 22–25.
2.
Xie, Jindong, Xinmei Lin, Xinpei Deng, et al.. (2025). Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment. Cancer Drug Resistance. 8. 2–2. 20 indexed citations breakdown →
3.
Zhang, Xiaoyu, Xiaoqing Zhang, Qing Bao, et al.. (2025). Cancer stem cell plasticity in shaping drug resistance landscapes in prostate cancer. Journal of Advanced Research.
4.
Zhang, Jinhui, Song Wu, Jindong Xie, et al.. (2025). PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer. Research. 8. 854–854. 2 indexed citations
5.
Xie, Jindong, Bo Lin, Weihong Tian, et al.. (2024). Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy. Advanced Science. 11(23). e2401061–e2401061. 35 indexed citations
6.
Xie, Jindong, Xinpei Deng, Yi Xie, et al.. (2024). Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer. SHILAP Revista de lepidopterología. 5(3). e502–e502. 44 indexed citations
7.
Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2024). Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. SHILAP Revista de lepidopterología. 3(1). e156–e156. 50 indexed citations breakdown →
8.
Zou, Yutian, Hanqi Zhang, Feng Liu, Zhe‐Sheng Chen, & Hailin Tang. (2024). Intratumoral microbiota in orchestrating cancer immunotherapy response. Journal of Translational Internal Medicine. 12(6). 540–542. 13 indexed citations
9.
Tian, W. H., Yuhui Tang, Jindong Xie, et al.. (2023). AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death and Disease. 14(12). 790–790. 17 indexed citations
10.
Xie, Jindong, Wei Deng, Xinpei Deng, et al.. (2023). Single-cell histone chaperones patterns guide intercellular communication of tumor microenvironment that contribute to breast cancer metastases. Cancer Cell International. 23(1). 311–311. 18 indexed citations
11.
Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2023). Circular RNA: A promising new star of vaccine. Journal of Translational Internal Medicine. 11(4). 372–381. 70 indexed citations
12.
Hu, Xiaoqian, Xinpei Deng, Jindong Xie, Hailin Tang, & Yutian Zou. (2023). Heterogeneous PD-L1 expression in metastases impacts immunotherapy response. EBioMedicine. 97. 104816–104816. 5 indexed citations
13.
Zou, Yutian, Feng Ye, Yanan Kong, et al.. (2022). The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced Science. 10(5). e2203699–e2203699. 191 indexed citations breakdown →
14.
Zou, Yutian, Shaoquan Zheng, Xinhua Xie, et al.. (2022). N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature Communications. 13(1). 2672–2672. 167 indexed citations breakdown →
15.
Xie, Jindong, Yutian Zou, Ting Gao, et al.. (2022). Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Cancer Control. 29. 2905517278–2905517278. 16 indexed citations
16.
Yang, Anli, Weikai Xiao, Shaoquan Zheng, et al.. (2021). Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer. Cancer Control. 28. 1149432682–1149432682. 5 indexed citations
17.
Yang, Lu, Ning Li, Jian Li, et al.. (2020). Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer. Cell Death and Differentiation. 27(7). 2066–2080. 31 indexed citations
18.
Xiao, Weikai, Yutian Zou, Shaoquan Zheng, et al.. (2018). Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology. 44(10). 1504–1512. 36 indexed citations
19.
Xie, Xinhua, Xinhua Xie, Jianwei Wang, et al.. (2018). Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer. Journal of Cellular and Molecular Medicine. 23(2). 1439–1447. 25 indexed citations
20.
Xiao, Weikai, Shaoquan Zheng, Peng Liu, et al.. (2018). Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study. Cancer Medicine. 7(3). 922–930. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica V. Estrada Breakdown of academic impact, for papers by Andreas Pircher Breakdown of academic impact, for papers by Haili Qian Breakdown of academic impact, for papers by Giulio Francia Breakdown of academic impact, for papers by Mohammed A. Aleskandarany Breakdown of academic impact, for papers by Adrian M. Jubb Breakdown of academic impact, for papers by Hege G. Russnes Breakdown of academic impact, for papers by Marco Gerlinger Breakdown of academic impact, for papers by Oddbjørn Straume Breakdown of academic impact, for papers by Matthias Bache
Rankless by CCL
2026